Phase II study of preoperative endocrine therapy vs chemotherapy in postmenopausal ER-positive breast cancer patients

被引：0
|
作者：
Semigiazov, Vladimir F. [1 ]
Ivanov, Vadim G. [1 ]
Bozhok, Alla A. [1 ]
Semiglazov, Vjacheslav V. [1 ]
Melnikova, Olga A. [1 ]
Kletzel, Alexander A. [1 ]
Topuzov, Eldar E. [1 ]
Paltuev, Ruslan M. [1 ]
Dashian, Garik A. [1 ]
Berstein, Lev M. [1 ]
机构：
[1] NN Petrov Oncol Res Inst, St Petersburg, Russia
来源：
ANNALS OF ONCOLOGY | 2004年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：55 / 55
页数：1
相关论文
共 50 条
  • [1] Primary endocrine therapy vs chemotherapy in postmenopausal ER-positive breast cancer patients
    不详
    [J]. EJC SUPPLEMENTS, 2006, 4 (02): : 117 - 117
  • [2] Neoadjuvant endocrine therapy vs chemotherapy for postmenopausal ER-positive breast cancer patients
    Semiglazov, VF
    Ivanov, VG
    Semiglazov, VV
    Ziltsova, EK
    Keltzel, AA
    Melnikova, OA
    Topuzov, EE
    Paltuev, RM
    Bozhok, AA
    Dashian, GA
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S106 - S107
  • [3] Preoperative hormonal therapy vs chemotherapy in postmenopausal ER-positive breast cancer patients
    Semiglazov, V. F.
    Semiglazov, V. V.
    Ivanov, V. G.
    Ziltsova, E. K.
    Dashian, G. A.
    Kletzel, A.
    Bozhok, A. A.
    Topuzov, E. E.
    Paltuev, R. M.
    Berstein, L. M.
    [J]. EJC SUPPLEMENTS, 2004, 2 (03): : 71 - 71
  • [4] The relative efficacy of neoadjuvant endocrine therapy vs chemotherapy in postmenopausal women with ER-positive breast cancer
    Semiglazov, VF
    Semiglazov, V
    Ivanov, V
    Bozhok, A
    Ziltsova, E
    Paltuev, R
    Dashian, G
    Kletzel, A
    Topuzov, E
    Berstein, L
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 7S - 7S
  • [5] Direct comparison of primary (neoadjuvant) endocrine therapy vs primary chemotherapy in postmenopausal women with ER-positive breast cancer
    不详
    [J]. BREAST, 2005, 14 : S39 - S39
  • [6] The neoadjuvant endocrinetherapy vs chemotherapy in postmenopausal woment with ER-positive breast cancer
    Semiglazov, V. F.
    Semiglazov, V. V.
    Ivanov, V. G.
    Zhiltzova, E. R.
    Kletsel, A. E.
    Dashyan, G. A.
    Bozhok, A. A.
    Paltuev, R. M.
    Berstein, L. M.
    Krivorotko, R. V.
    [J]. BREAST, 2007, 16 : S50 - S50
  • [7] Primary endocrine therapy versus chemotherapy in postmenopausal patients with ER-positive breast cancer: 5-year results
    Semiglazov, V. F.
    Dashyan, G. A.
    Semiglazov, Vv.
    Ziltsova, E. K.
    Malodusheva, A. A.
    Ivanov, V. G.
    Donskih, R. V.
    Bozhok, A. A.
    Palluev, R. M.
    Berstein, L. M.
    [J]. BREAST, 2009, 18 : S63 - S63
  • [8] Fulvestrant in heavily pretreated ER-positive postmenopausal metastatic breast cancer patients: A phase II study
    Ratti, R.
    Coccorullo, Z.
    Guarneri, D.
    Addamo, G.
    Colloca, G.
    Venturino, A.
    Campora, E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [9] Neoadjuvant endocrine therapy: A potential strategy for ER-positive breast cancer
    Li-Tong Yao
    Mo-Zhi Wang
    Meng-Shen Wang
    Xue-Ting Yu
    Jing-Yi Guo
    Tie Sun
    Xin-Yan Li
    Ying-Ying Xu
    [J]. World Journal of Clinical Cases, 2019, (15) : 1937 - 1953
  • [10] Neoadjuvant endocrine therapy: A potential strategy for ER-positive breast cancer
    Yao, Li-Tong
    Wang, Mo-Zhi
    Wang, Meng-Shen
    Yu, Xue-Ting
    Guo, Jing-Yi
    Sun, Tie
    Li, Xin-Yan
    Xu, Ying-Ying
    [J]. WORLD JOURNAL OF CLINICAL CASES, 2019, 7 (15) : 1937 - 1953
12345